© 2018, The Author(s). Rapidly evolving cell-based therapies towards clinical trials demand alternative approaches for efficient expansion of adherent cell types such as human mesenchymal stem cells (hMSCs). Using microcarriers (100–300 µm) in a stirred tank bioreactor offers considerably enhanced surface to volume ratio of culture environment. However, downstream purification of the harvested cell product needs to be addressed carefully due to distinctive features and fragility of these cell products. This work demonstrates a novel alternative approach which utilizes inertial focusing to separate microcarriers (MCs) from the final cell suspension. First, we systematically investigated MC focusing dynamics inside scaled-up curved channels w...
AbstractThe use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will nece...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
Rapidly evolving cell-based therapies towards clinical trials demand alternative approaches for effi...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
For the first time, fully functional human mesenchymal stem cells (hMSCs) have been cultured at the ...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
AbstractThe use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will nece...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
Rapidly evolving cell-based therapies towards clinical trials demand alternative approaches for effi...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a la...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
For the first time, fully functional human mesenchymal stem cells (hMSCs) have been cultured at the ...
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advanc...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
The use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will necessitate ...
AbstractThe use of hMSCs for allogeneic therapies requiring lot sizes of billions of cells will nece...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...